These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23134660)

  • 1. Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers.
    Quiroz YT; Stern CE; Reiman EM; Brickhouse M; Ruiz A; Sperling RA; Lopera F; Dickerson BC
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):556-61. PubMed ID: 23134660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.
    Weston PS; Nicholas JM; Lehmann M; Ryan NS; Liang Y; Macpherson K; Modat M; Rossor MN; Schott JM; Ourselin S; Fox NC
    Neurology; 2016 Nov; 87(19):2050-2057. PubMed ID: 27733562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.
    Quiroz YT; Willment KC; Castrillon G; Muniz M; Lopera F; Budson A; Stern CE
    J Alzheimers Dis; 2015; 47(4):955-64. PubMed ID: 26401774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations.
    Lee GJ; Lu PH; Medina LD; Rodriguez-Agudelo Y; Melchor S; Coppola G; Braskie MN; Hua X; Apostolova LG; Leow AD; Thompson PM; Ringman JM
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):154-62. PubMed ID: 23085935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.
    Reiman EM; Quiroz YT; Fleisher AS; Chen K; Velez-Pardo C; Jimenez-Del-Rio M; Fagan AM; Shah AR; Alvarez S; Arbelaez A; Giraldo M; Acosta-Baena N; Sperling RA; Dickerson B; Stern CE; Tirado V; Munoz C; Reiman RA; Huentelman MJ; Alexander GE; Langbaum JB; Kosik KS; Tariot PN; Lopera F
    Lancet Neurol; 2012 Dec; 11(12):1048-56. PubMed ID: 23137948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer's disease.
    Weston PSJ; Poole T; Nicholas JM; Toussaint N; Simpson IJA; Modat M; Ryan NS; Liang Y; Rossor MN; Schott JM; Ourselin S; Zhang H; Fox NC
    Alzheimers Res Ther; 2020 Sep; 12(1):112. PubMed ID: 32943095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study.
    Vila-Castelar C; Guzmán-Vélez E; Pardilla-Delgado E; Buckley RF; Bocanegra Y; Baena A; Fox-Fuller JT; Tirado V; Muñoz C; Giraldo M; Acosta-Baena N; Rios-Romenets S; Langbaum JB; Tariot PN; Lopera F; Reiman EM; Quiroz YT
    J Alzheimers Dis; 2020; 77(4):1743-1753. PubMed ID: 32925067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease.
    Quiroz YT; Budson AE; Celone K; Ruiz A; Newmark R; Castrillón G; Lopera F; Stern CE
    Ann Neurol; 2010 Dec; 68(6):865-75. PubMed ID: 21194156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.
    Fleisher AS; Chen K; Quiroz YT; Jakimovich LJ; Gomez MG; Langois CM; Langbaum JB; Ayutyanont N; Roontiva A; Thiyyagura P; Lee W; Mo H; Lopez L; Moreno S; Acosta-Baena N; Giraldo M; Garcia G; Reiman RA; Huentelman MJ; Kosik KS; Tariot PN; Lopera F; Reiman EM
    Lancet Neurol; 2012 Dec; 11(12):1057-65. PubMed ID: 23137949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers.
    Guzmán-Vélez E; Martínez J; Papp K; Baena A; Vila-Castelar C; Artola A; Schultz AP; Bocanegra Y; Sanchez J; Rentz D; Tariot PN; Reiman EM; Sperling R; Johnson KA; Lopera F; Quiroz YT
    Neurology; 2020 Sep; 95(10):e1312-e1321. PubMed ID: 32611637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers.
    Fortea J; Sala-Llonch R; Bartrés-Faz D; Bosch B; Lladó A; Bargalló N; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2010; 22(3):909-22. PubMed ID: 20858974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of cortical thinning in familial Alzheimer's disease.
    Knight WD; Kim LG; Douiri A; Frost C; Rossor MN; Fox NC
    Neurobiol Aging; 2011 Oct; 32(10):1765-73. PubMed ID: 20005601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease.
    Apostolova LG; Hwang KS; Medina LD; Green AE; Braskie MN; Dutton RA; Lai J; Geschwind DH; Cummings JL; Thompson PM; Ringman JM
    Dement Geriatr Cogn Disord; 2011; 32(2):118-25. PubMed ID: 21952501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease.
    Vilaplana E; Rodriguez-Vieitez E; Ferreira D; Montal V; Almkvist O; Wall A; Lleó A; Westman E; Graff C; Fortea J; Nordberg A
    Neurology; 2020 May; 94(19):e2026-e2036. PubMed ID: 32291295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study.
    Cash DM; Ridgway GR; Liang Y; Ryan NS; Kinnunen KM; Yeatman T; Malone IB; Benzinger TL; Jack CR; Thompson PM; Ghetti BF; Saykin AJ; Masters CL; Ringman JM; Salloway SP; Schofield PR; Sperling RA; Cairns NJ; Marcus DS; Xiong C; Bateman RJ; Morris JC; Rossor MN; Ourselin S; Fox NC;
    Neurology; 2013 Oct; 81(16):1425-33. PubMed ID: 24049139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease.
    Braskie MN; Medina LD; Rodriguez-Agudelo Y; Geschwind DH; Macias-Islas MA; Thompson PM; Cummings JL; Bookheimer SY; Ringman JM
    Hum Brain Mapp; 2013 Dec; 34(12):3308-19. PubMed ID: 22806961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities and patterns of atrophy in early onset Alzheimer's disease with causative gene mutations.
    Mao C; Li J; Huang X; Dong L; Liu C; Peng B; Cui L; Gao J
    Clin Neurol Neurosurg; 2021 Apr; 203():106552. PubMed ID: 33601235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing familial corticobasal syndrome due to Alzheimer's disease pathology and PSEN1 mutations.
    Lam B; Khan A; Keith J; Rogaeva E; Bilbao J; St George-Hyslop P; Ghani M; Freedman M; Stuss DT; Chow T; Black SE; Masellis M
    Alzheimers Dement; 2017 May; 13(5):520-530. PubMed ID: 27743520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving brain structural changes in PSEN1 mutation carriers.
    Sala-Llonch R; Lladó A; Fortea J; Bosch B; Antonell A; Balasa M; Bargalló N; Bartrés-Faz D; Molinuevo JL; Sánchez-Valle R
    Neurobiol Aging; 2015 Mar; 36(3):1261-70. PubMed ID: 25638532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.